Aimpart (ropinirole): Reviews and patient testimonials
Back to the list of medications
Medication indications
Aimpart XL 2mg prolonged-release tablets
Treatment of Parkinson's disease under the following conditions:• Initial treatment as monotherapy, in order to delay the introduction of levodopa • In combination with levodopa, over the course of the disease, when the effect of levodopa wears off or becomes inconsistent and fluctuations in the therapeutic effect occur (end of dose or on-off type fluctuations).Aimpart XL 4mg prolonged-release tablets
Treatment of Parkinson's disease under the following conditions:• Initial treatment as monotherapy, in order to delay the introduction of levodopa• In combination with levodopa, over the course of the disease, when the effect of levodopa wears off or becomes inconsistent and fluctuations in the therapeutic effect occur (end of dose or on-off type fluctuations).Aimpart XL 8mg prolonged-release tablets
Treatment of Parkinson's disease under the following conditions:• Initial treatment as monotherapy, in order to delay the introduction of levodopa• In combination with levodopa, over the course of the disease, when the effect of levodopa wears off or becomes inconsistent and fluctuations in the therapeutic effect occur (end of dose or on-off type fluctuations).Route of administration: Oral
Molecule: ropinirole
Patients' opinions on Aimpart
Conditions related to this medication
Fact sheet
See the fact sheet
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.